Orgenesis Inc. announced that it has entered into a securities purchase agreement to issue 1,410,256 shares at a price of $0.78 per unit and warrants at a price of $1.1 million on November 8, 2023. The warrants will be exercisable immediately following the date of issuance and may be exercised for a period of five years from the initial exercisability date at an exercise price of $0.78 per share. The transaction is expected to close on November 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.58 USD | +4.69% | +10.06% | +15.84% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+15.84% | 19.75M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it expects to receive $1.1 million in funding